Review article · 2023
Evaluating physiochemical properties of FDA-approved orally administered drugs
Expert Opinion on Drug Discovery, 19(2), 225–238 · Published 3 November 2023 · DOI 10.1080/17460441.2023.2275617
In brief
“Evaluating physiochemical properties of FDA-approved orally administered drugs” is a 2023 review article by Tanner C. Reese and 5 co-authors, published in Expert Opinion on Drug Discovery. OpenAlex counts 21 citations as of 15 November 2026, which puts it in the top 5% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 21
- Most cited in
- 2026 (12)
- Field-weighted impact
- 0.34
- References
- 156
- Authors
- 6
Abstract
INTRODUCTION: Analyses of orally administered FDA-approved drugs from 1990 to 1993 enabled the identification of a set of physiochemical properties known as Lipinski's Rule of Five (Ro5). The original Ro5 and extended versions still remain the reference criteria for drug development programs. Since many bioactive compounds do not conform to the Ro5, we validated the… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Reese, T. C., Devineni, A., Smith, T., Lalami, I., Ahn, J., & Raj, G. V. (2023). Evaluating physiochemical properties of FDA-approved orally administered drugs. Expert Opinion on Drug Discovery, 19(2), 225–238. https://doi.org/10.1080/17460441.2023.2275617
MLA 9
Reese, Tanner C., et al. “Evaluating physiochemical properties of FDA-approved orally administered drugs.” Expert Opinion on Drug Discovery, vol. 19, no. 2, 2023, pp. 225–238. https://doi.org/10.1080/17460441.2023.2275617.
Chicago
Reese, Tanner C., Anvita Devineni, Tristan Smith, Ismail Lalami, Jung‐Mo Ahn, and Ganesh V. Raj. 2023. “Evaluating physiochemical properties of FDA-approved orally administered drugs.” Expert Opinion on Drug Discovery 19 (2): 225–238. https://doi.org/10.1080/17460441.2023.2275617.
Harvard
Reese, T. C. et al. (2023) ‘Evaluating physiochemical properties of FDA-approved orally administered drugs’, Expert Opinion on Drug Discovery, 19(2), pp. 225–238. doi:10.1080/17460441.2023.2275617.
IEEE
T. C. Reese, A. Devineni, T. Smith, I. Lalami, J. Ahn, and G. V. Raj, “Evaluating physiochemical properties of FDA-approved orally administered drugs,” Expert Opinion on Drug Discovery, vol. 19, no. 2, pp. 225–238, 2023, doi: 10.1080/17460441.2023.2275617.
BibTeX
@article{reese2023evaluating,
title = {{Evaluating physiochemical properties of FDA-approved orally administered drugs}},
author = {Reese, Tanner C. and Devineni, Anvita and Smith, Tristan and Lalami, Ismail and Ahn, Jung‐Mo and Raj, Ganesh V.},
journal = {Expert Opinion on Drug Discovery},
year = {2023},
volume = {19},
number = {2},
pages = {225--238},
doi = {10.1080/17460441.2023.2275617},
url = {https://doi.org/10.1080/17460441.2023.2275617}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 3 | |
| 2025 | 6 | |
| 2026 | 12 |
Its field-weighted citation impact is 0.34: it has been cited 0.34 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Lipinski's rule of five
- physicochemical properties
- oral bioavailability
- drug-likeness
- drug development
- chemical diversity
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Reese, T. C., Devineni, A., Smith, T., Lalami, I., Ahn, J., & Raj, G. V. (2023). Evaluating physiochemical properties of FDA-approved orally administered drugs. Expert Opinion on Drug Discovery, 19(2), 225–238. https://doi.org/10.1080/17460441.2023.2275617
How many times has this paper been cited?
21 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Tanner C. Reese, Anvita Devineni, Tristan Smith, Ismail Lalami, Jung‐Mo Ahn, Ganesh V. Raj.
What is the DOI of this paper?
10.1080/17460441.2023.2275617. The permanent link is https://doi.org/10.1080/17460441.2023.2275617.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.